abstract [00321] in some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. in some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. in some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. in some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. in some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. in some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. patent abstract: "directed, cell reaction or long acting compstatin analogs and uses thereof". In some aspects, the present invention provides cell reaction compstatin analogs and compositions comprising cell reaction compstatin analogs. In some aspects, the invention further provides methods for the use of cell reaction compstatin analogs, for example, for inhibiting complement-mediated damage to a cell, tissue or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods for the use of long-acting compstatin analogs, for example for inhibiting complement-mediated damage to a cell, tissue or organ. In some aspects, the invention provides directed compstatin analogs and compositions comprising directed compstatin analogs. In some aspects, the invention further provides methods for the use of compstatin analogs directed, for example, to inhibiting complement-mediated damage to a cell, tissue or organ.abstract [00321] in some as
